A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamis and Efficacy of VT-464 in Patients with Advanced Breast Cancer

December 29, 2016

Type of Cancer

Breast Oncology

Site

Hackensack

Sponsor

Innocrin

Protocol Number

INO-VT-464-CL-006

To Learn More Call

201-510-0910